E. Moreno-Clavijo et al. / Tetrahedron Letters 48 (2007) 159–162
161
Boc
N
and for the award of a Grant to E.M.-C., the European
Commission (FP6, TRIoH, LSHG-CT-2003-503480)
Boc
N
Me
Me
Me
c
Me
COOEt
CHO
´
and the Junta de Andalucıa (FQM-345). We also thank
(74%)
Professor P. Vogel for helpful discussions.
O
O
13
O
O
17
a
d
(85%)
(69%)
References and notes
Boc
Boc
H
H
N
N
N
N
Me
Ar
Ar
1. (a) Iminosugars as Glycosidase Inhibitors. Nojirimycin and
O
Beyond; Stutz, A. E., Ed.; Wiley-VCH: Weinheim, Ger-
¨
O
O
b
O
O
18
many, 1999; (b) Goss, P. E.; Baptiste, J.; Fernandes, B.;
Baker, M.; Dennis, J. W. Cancer Res. 1994, 54, 1450–1457;
(c) Fiaux, H.; Popowycz, F.; Favre, S.; Schutz, C.; Vogel,
P.; Gerber-Lemaire, S.; Juillerat-Jeanneret, L. J. Med.
Chem. 2005, 48, 4237–4246; (d) Robina, I.; Moreno-
Vargas, A. J.; Carmona, A. T.; Vogel, P. Curr. Drug
Metabol. 2004, 5, 329–361.
16
Ar:1-biphenyl
Ar: 1-naphtyl
e
(84%)
(62%)
H
N
H
H
N
H
N
N
Me
HO
2. (a) Dalko, P. I.; Moisan, L. Angew. Chem., Int. Ed. 2004,
43, 5138–5175; (b) Shi, Y. Acc. Chem. Res. 2004, 37, 488–
496; (c) Tomioka, K. Synthesis 1990, 541–549.
OH
8
HO
OH
7
3. (a) Whitesell, J. K. Chem. Rev. 1989, 89, 1581–1590; (b)
Sweet, J. A.; Cavallari, J. M.; Price, W. A.; Ziller, J. W.;
McGrath, D. V. Tetrahedron: Asymmetry 1997, 8, 207–
211; (c) Kim, B. H.; Lee, H. B.; Hwang, J. K.; Kim, Y. G.
Tetrahedron: Asymmetry 2005, 16, 1215–1220; (d) Ni, Y.;
Kande, K. D.; Amarsinghe, K. K. D.; Ksebati, B.;
Montgomery, J. Org. Lett. 2003, 5, 3771–3773.
Scheme 4. Synthesis of aryl aminoethyl pyrrolidines 7 and 8. Reagents
and conditions: (a) (1) NaOH, EtOH; (2) biphenyl-4-amine, PyBOP,
DIPEA, DMF; (b) (1) BH3, SMe2, THF; (2) HCl, THF; (3) NH4OH;
(c) DIBALH, CH2Cl2, À78 °C; (d) naphthalene-1-amine, NaBH-
(OAc)3, (CH2Cl)2 and (e) (1) HCl, THF; (2) NH4OH.
4. Wheatley, J. R.; Nash, R. J.; Watson, A. A.; Griffiths, R.
C.; Butters, T. D.; Muller, M.; Watkin, D. J.; Winkler, D.
A.; Fleet, G. W. J. J. Chem. Soc., Perkin Trans. 1 1999,
2735–2745.
5. (a) Dondoni, A.; Giovannini, P. P.; Perrone, D. J. Org.
Chem. 2002, 67, 7203–7214; (b) Asiego, C.; Pino-Gonz-
Reduction with BH3ÆSMe2 followed by acidic deprotec-
tion gave 7 in a 84% overall yield. The same procedure
applied to the preparation of 8 gave a poor yield. Thus,
compound 8 was obtained by the reductive amination of
aldehyde 17 with naphthalene-1-amine (85%) followed
by acidic deprotection. Carbaldehyde 17 was obtained
from 13 by reduction with DIBALH in a 74% yield
(Scheme 4).
´
alez, M. S.; Lopez-Herrera, F. J. Tetrahedron Lett. 2004,
45, 2611–2613; (c) Cardona, F.; Robina, I.; Vogel, P. J.
Carbohydr. Chem. 2000, 19, 555–571; (d) Marquis, C.;
Cardona, F.; Robina, I.; Wurth, G.; Vogel, P. Hetero-
cycles 2002, 56, 181–208; For a review on aza-disaccha-
rides containing homoazasugar moieties: (e) Robina, I.;
Vogel, P. Synthesis 2005, 675–702.
In summary, we have presented a highly stereoselective
procedure for the preparation of (2S and 2R,3S,4R,5S)-
5-methyl-3,4-dihydroxy-2-ethoxycarbonylmethylpyrrol-
idines based on the conjugate addition of ammonia to
unsaturated aldonic esters derived from D-ribose and
tandem cyclization. Derivatisation of these compounds
to hydroxyethyl-pyrrolidine 5, benzymidazolyl-pyrrol-
idine 6 and biphenyl- and naphthalene-l-aminoethyl-
pyrrolidines 7 and 8 is also presented.
6. (a) Joubert, M.; Defoin, A.; Tarmus, C.; Streith, J. Synlett
2000, 1366–1368; (b) Wong, C.-H.; Provencher, L.; Porco,
J. A., Jr.; Jung, S.-H.; Wang, Y.-F.; Chen, L.; Wang, R.;
Steensma, D. H. J. Org. Chem. 1995, 60, 1492–1501; (c)
Sifferlen, T.; Defoin, A.; Streith, J.; Le Noue¨n, D.; Tarnus,
C.; Dosbaˆo, I.; Foglietti, M.-J. Tetrahedron 2000, 56, 971–
978; (d) Chevrier, C.; Le Noue¨n, D.; Neuburger, M.;
Defoin, A.; Tarnus, C. Tetrahedron Lett. 2004, 45, 5363–
5367.
The new compounds presented in this letter show the
introduction of several structural modifications to our
reported pyrrolidine derivatives10d such as, the spacer
between the N of the pyrrolidine ring and the amino-
alkyl side chain, the configuration of the pyrrolidine
moiety at C-2, and the nature of the substituent attached
to the pyrrolidine framework (CH2CH2OH, CH2CH2-
NHAr, CH2Ar). This diversity will hopefully provide
useful information on the structure/activity relation-
ships in glycosidase inhibition assays. These studies will
be reported in due time.
7. (a) Legler, C. Adv. Carbohydr. Chem. Biochem. 1990, 48,
319–384; (b) Charnock, S. J.; Spurway, T. D.; Xie, H.;
Beylot, M.-H.; Virden, R.; Warren, R. A. J.; Hazlewood,
G. P.; Gilbert, H. J. J. Biol. Chem. 1998, 273, 32187–
32199.
8. For results on a-mannosidases see: (a) Gerber-Lemaire, S.;
´
´
Popowycz, F.; Rodrıguez-Garcıa, E.; Carmona Asenjo, A.
T.; Robina, I.; Vogel, P. Chem. BioChem. 2002, 3, 466–
´
470; (b) Gerber-Lemaire, S.; Popowycz, F.; Rodrıguez-
´
Garcıa, E.; Schuetz, C.; Carmona Asenjo, A. T.; Robina,
I.; Vogel, P. ARKIVOC 2002, 23–37; (c) Carmona, A. T.;
´
´
Popowycz, F.; Gerber-Lemaire, S.; Rodrıguez-Garcıa, E.;
Schutz, C.; Vogel, P.; Robina, I. Bioorg. Med. Chem. 2003,
11, 4897–4911; (d) Popowycz, F.; Gerber-Lemaire, S.;
Schutz, C.; Vogel, P. Helv. Chim. Acta 2004, 87, 800–
810.
Acknowledgements
´
We thank the Ministerio de Educacion y Ciencia of
9. For results on a-glucosidases, see: (a) Lysek, R.; Vogel, P.
Tetrahedron 2006, 62, 2733–2768; (b) Lysek, R.; Schutz,
Spain for financial support (CTQ2004-00649/BQU)